1. Home
  2. NMRA vs LXFR Comparison

NMRA vs LXFR Comparison

Compare NMRA & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LXFR
  • Stock Information
  • Founded
  • NMRA 2019
  • LXFR 1898
  • Country
  • NMRA United States
  • LXFR United States
  • Employees
  • NMRA N/A
  • LXFR N/A
  • Industry
  • NMRA
  • LXFR Major Chemicals
  • Sector
  • NMRA
  • LXFR Industrials
  • Exchange
  • NMRA Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • NMRA 287.6M
  • LXFR 274.4M
  • IPO Year
  • NMRA 2023
  • LXFR 2012
  • Fundamental
  • Price
  • NMRA $0.66
  • LXFR $11.57
  • Analyst Decision
  • NMRA Buy
  • LXFR
  • Analyst Count
  • NMRA 8
  • LXFR 0
  • Target Price
  • NMRA $9.29
  • LXFR N/A
  • AVG Volume (30 Days)
  • NMRA 891.0K
  • LXFR 124.2K
  • Earning Date
  • NMRA 05-12-2025
  • LXFR 04-29-2025
  • Dividend Yield
  • NMRA N/A
  • LXFR 4.49%
  • EPS Growth
  • NMRA N/A
  • LXFR 49063.50
  • EPS
  • NMRA N/A
  • LXFR 0.79
  • Revenue
  • NMRA N/A
  • LXFR $399,500,000.00
  • Revenue This Year
  • NMRA N/A
  • LXFR $1.09
  • Revenue Next Year
  • NMRA N/A
  • LXFR $5.87
  • P/E Ratio
  • NMRA N/A
  • LXFR $14.71
  • Revenue Growth
  • NMRA N/A
  • LXFR 1.63
  • 52 Week Low
  • NMRA $0.62
  • LXFR $9.41
  • 52 Week High
  • NMRA $17.19
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 31.99
  • LXFR 61.24
  • Support Level
  • NMRA $0.63
  • LXFR $10.67
  • Resistance Level
  • NMRA $0.72
  • LXFR $11.81
  • Average True Range (ATR)
  • NMRA 0.06
  • LXFR 0.45
  • MACD
  • NMRA 0.02
  • LXFR 0.23
  • Stochastic Oscillator
  • NMRA 18.80
  • LXFR 89.79

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: